Kiniksa Pharmaceuticals, Ltd.
KNSA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$43,193 | $14,084 | $183,363 | -$157,924 |
| Dep. & Amort. | $1,695 | $2,341 | $2,402 | $2,355 |
| Deferred Tax | $8,132 | -$33,788 | -$185,495 | $11 |
| Stock-Based Comp. | $30,693 | $27,149 | $25,120 | $25,173 |
| Change in WC | $24,809 | $1,350 | -$22,575 | $689 |
| Other Non-Cash | $3,553 | $2,165 | $2,992 | $3,398 |
| Operating Cash Flow | $25,689 | $13,301 | $5,807 | -$126,298 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$277 | -$130 | -$105 | -$415 |
| Net Acquisitions | $25 | $0 | $0 | $0 |
| Inv. Purchases | -$202,014 | -$204,933 | -$135,864 | -$157,250 |
| Inv. Sales/Matur. | $239,938 | $175,506 | $127,800 | $306,300 |
| Other Inv. Act. | $0 | $0 | $91 | -$20,000 |
| Investing Cash Flow | $37,672 | -$29,557 | -$8,078 | $128,635 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $3,417 | $0 |
| Stock Repurch. | -$4,984 | -$2,206 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $17,250 | $3,701 | -$901 | $5,885 |
| Financing Cash Flow | $12,266 | $1,495 | $2,516 | $5,885 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $75,627 | -$14,761 | $245 | $8,222 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $107,954 | $122,715 | $122,470 | $114,248 |
| End Cash | $183,581 | $107,954 | $122,715 | $122,470 |
| Free Cash Flow | $25,412 | $13,171 | $5,702 | -$146,713 |